Venous thromboembolism after hip arthroscopy: a systematic review of incidence, risk factors, and international guidelines
Research article published in Frontiers in surgery (2025)
Abstract
PURPOSE: This review aims to systematically evaluate the incidence, risk factors, and international guideline discrepancies for venous thromboembolism (VTE) following hip arthroscopy (HA). METHODOLOGY: A search of four databases from the inception to April 20, 2025, identified studies reporting VTE outcomes post-HA. Relevant practice guideline recommendations were concurrently analyzed. RESULTS: Twenty-one studies encompassing 135,377 patients and five clinical guidelines were included. Female patients constituted 91,013 cases (67.2%). The mean patient age was 37.08 years; however, the average follow-up duration was limited to 3.7 months, which may be a study limitation. Pooled incidence rates were: deep vein thrombosis (DVT) 0.441%, pulmonary embolism (PE) 0.216%, and overall VTE 0.656%. The majority of studies were Level IV evidence (57%), with Level III evidence comprising 33%. Identified risk factors for post-HA VTE included obesity, oral contraceptive use, ≥45 years, overweight status, coagulopathy, and arteriovenous anomalies. The reported VTE incidence ranged from 0% to 6.94%. International guidelines vary, but most advocate for risk-stratified thromboprophylaxis. CONCLUSIONS: The incidence of VTE following hip arthroscopy is low. Routine pharmacological thromboprophylaxis may not be necessary for standard-risk patients. However, high-risk individuals warrant personalized prophylaxis regimens, with pharmacological prophylaxis when clinically indicated based on risk assessment.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.
Por qué esto importa para la hirudoterapia
Esta revisión sistemática de 21 estudios (135,377 pacientes) y cinco guías encontró una incidencia combinada baja de tromboembolismo venoso tras la artroscopia de cadera (DVT 0.441%, PE 0.216%, VTE global 0.656%), identificó factores de riesgo como la obesidad, el uso de anticonceptivos orales y la edad, y concluyó que la tromboprofilaxis farmacológica rutinaria puede ser innecesaria para pacientes de riesgo estándar, mientras que los individuos de alto riesgo justifican una profilaxis personalizada. Para la hirudoterapia, esto proporciona un contexto sobre la toma de decisiones antitrombóticas estratificadas por riesgo en cirugía —el mismo marco individualizado de riesgo-beneficio que debe regir cualquier consideración sobre la exposición a anticoagulantes, incluidos los efectos locales derivados de sanguijuelas, en torno a los procedimientos. La salvedad es que la evidencia incluida fue predominantemente de bajo nivel (Nivel IV/III) con un seguimiento corto, y la revisión se refiere a la tromboprofilaxis farmacológica convencional sin componente de sanguijuelas, por lo que solo informa el contexto general de la anticoagulación quirúrgica.
Citación
Venous thromboembolism after hip arthroscopy: a systematic review of incidence, risk factors, and international guidelines.
Gao et al. · Frontiers in surgery, 2025
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: June 18, 2026